Strategies to overcome therapeutic resistance in renal cell carcinoma.
about
Regulation of spindle and kinetochore-associated protein 1 by antitumor miR-10a-5p in renal cell carcinoma.HDAC inhibition as a treatment concept to combat temsirolimus-resistant bladder cancer cells.The suppressing role of miR-622 in renal cell carcinoma progression by down-regulation of CCL18/MAPK signal pathway.The expression and function of RASAL2 in renal cell carcinoma angiogenesis
P2860
Strategies to overcome therapeutic resistance in renal cell carcinoma.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Strategies to overcome therapeutic resistance in renal cell carcinoma.
@en
Strategies to overcome therapeutic resistance in renal cell carcinoma.
@nl
type
label
Strategies to overcome therapeutic resistance in renal cell carcinoma.
@en
Strategies to overcome therapeutic resistance in renal cell carcinoma.
@nl
prefLabel
Strategies to overcome therapeutic resistance in renal cell carcinoma.
@en
Strategies to overcome therapeutic resistance in renal cell carcinoma.
@nl
P2093
P2860
P1433
P1476
Strategies to overcome therapeutic resistance in renal cell carcinoma.
@en
P2093
Kathryn E Beckermann
Peter J Siska
Scott M Haake
W Kimryn Rathmell
P2860
P304
P356
10.1016/J.UROLONC.2016.12.002
P577
2017-01-11T00:00:00Z